Concepts (90)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fibroblast Growth Factors | 5 | 2017 | 859 | 0.880 |
Why?
|
| Caveolae | 1 | 2017 | 55 | 0.580 |
Why?
|
| Caveolins | 1 | 2017 | 102 | 0.570 |
Why?
|
| Myocytes, Cardiac | 5 | 2017 | 1611 | 0.520 |
Why?
|
| Cardiomegaly | 1 | 2017 | 592 | 0.470 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2017 | 2225 | 0.270 |
Why?
|
| Thrombosis | 2 | 2024 | 2998 | 0.170 |
Why?
|
| Heart | 1 | 2011 | 4359 | 0.160 |
Why?
|
| Sarcolemma | 1 | 2017 | 65 | 0.150 |
Why?
|
| Outpatients | 1 | 2024 | 1553 | 0.130 |
Why?
|
| Membrane Microdomains | 1 | 2017 | 206 | 0.130 |
Why?
|
| Pressure | 1 | 2017 | 1150 | 0.110 |
Why?
|
| Brugada Syndrome | 1 | 2013 | 96 | 0.100 |
Why?
|
| Ion Channels | 1 | 2017 | 1043 | 0.100 |
Why?
|
| Munc18 Proteins | 1 | 2011 | 25 | 0.100 |
Why?
|
| Calcium Channels, L-Type | 1 | 2013 | 235 | 0.100 |
Why?
|
| Pore Forming Cytotoxic Proteins | 1 | 2011 | 133 | 0.100 |
Why?
|
| Venous Thromboembolism | 1 | 2023 | 1770 | 0.090 |
Why?
|
| Fibrosis | 1 | 2017 | 2012 | 0.090 |
Why?
|
| Disease Models, Animal | 4 | 2017 | 17869 | 0.080 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 1 | 2011 | 261 | 0.080 |
Why?
|
| Endoderm | 1 | 2006 | 154 | 0.060 |
Why?
|
| Mice, Knockout | 2 | 2017 | 14253 | 0.060 |
Why?
|
| Myocardium | 1 | 2017 | 4634 | 0.060 |
Why?
|
| Mutation, Missense | 1 | 2013 | 2541 | 0.060 |
Why?
|
| Xenopus | 1 | 2006 | 711 | 0.060 |
Why?
|
| Sodium Channels | 2 | 2017 | 342 | 0.050 |
Why?
|
| Rats | 3 | 2013 | 23696 | 0.050 |
Why?
|
| DNA | 1 | 2013 | 7208 | 0.040 |
Why?
|
| Animals | 7 | 2017 | 166558 | 0.040 |
Why?
|
| Membrane Proteins | 2 | 2013 | 7786 | 0.040 |
Why?
|
| Peptides | 1 | 2010 | 4321 | 0.040 |
Why?
|
| Action Potentials | 2 | 2017 | 1773 | 0.040 |
Why?
|
| Mutation | 2 | 2011 | 29627 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2017 | 17445 | 0.030 |
Why?
|
| Venous Thrombosis | 1 | 2024 | 1267 | 0.030 |
Why?
|
| DNA Mutational Analysis | 2 | 2013 | 4122 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2017 | 788 | 0.030 |
Why?
|
| Mice | 4 | 2017 | 80251 | 0.030 |
Why?
|
| Gene Targeting | 1 | 2017 | 838 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2013 | 8131 | 0.030 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2024 | 2071 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2006 | 7572 | 0.030 |
Why?
|
| Electrocardiography | 2 | 2017 | 6319 | 0.030 |
Why?
|
| Male | 6 | 2024 | 351420 | 0.020 |
Why?
|
| Perforin | 1 | 2011 | 169 | 0.020 |
Why?
|
| Risk Factors | 2 | 2024 | 72447 | 0.020 |
Why?
|
| Vaccination | 1 | 2023 | 3283 | 0.020 |
Why?
|
| Female | 6 | 2024 | 382450 | 0.020 |
Why?
|
| Patch-Clamp Techniques | 1 | 2013 | 937 | 0.020 |
Why?
|
| Antiviral Agents | 1 | 2023 | 3017 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2013 | 1553 | 0.020 |
Why?
|
| 3T3 Cells | 1 | 2010 | 1084 | 0.020 |
Why?
|
| Registries | 1 | 2024 | 8173 | 0.020 |
Why?
|
| Tachycardia, Ventricular | 1 | 2017 | 1285 | 0.020 |
Why?
|
| Cells, Cultured | 2 | 2013 | 18905 | 0.020 |
Why?
|
| Genetic Loci | 1 | 2017 | 2556 | 0.020 |
Why?
|
| Models, Animal | 1 | 2013 | 2116 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2006 | 12044 | 0.020 |
Why?
|
| Protein Engineering | 1 | 2010 | 534 | 0.020 |
Why?
|
| Gastrula | 1 | 2006 | 82 | 0.020 |
Why?
|
| Incidence | 1 | 2024 | 20820 | 0.020 |
Why?
|
| Microinjections | 1 | 2006 | 322 | 0.020 |
Why?
|
| Adult | 4 | 2024 | 215192 | 0.020 |
Why?
|
| Age of Onset | 1 | 2011 | 3249 | 0.020 |
Why?
|
| Adolescent | 3 | 2023 | 86278 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2011 | 3534 | 0.010 |
Why?
|
| Oligopeptides | 1 | 2010 | 1188 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2013 | 3452 | 0.010 |
Why?
|
| Organ Culture Techniques | 1 | 2006 | 798 | 0.010 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2006 | 451 | 0.010 |
Why?
|
| Xenopus Proteins | 1 | 2006 | 433 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 2010 | 3089 | 0.010 |
Why?
|
| Embryo, Nonmammalian | 1 | 2006 | 898 | 0.010 |
Why?
|
| Pregnancy | 1 | 2024 | 29297 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 2006 | 1903 | 0.010 |
Why?
|
| Aged | 3 | 2023 | 164383 | 0.010 |
Why?
|
| Calcium | 1 | 2013 | 5656 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2013 | 11050 | 0.010 |
Why?
|
| Middle Aged | 3 | 2024 | 214618 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 4586 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 2024 | 15319 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2006 | 3787 | 0.010 |
Why?
|
| Young Adult | 2 | 2013 | 57163 | 0.010 |
Why?
|
| Phenotype | 1 | 2013 | 16261 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2013 | 21600 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2006 | 3578 | 0.010 |
Why?
|
| Humans | 4 | 2024 | 746630 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2013 | 57586 | 0.000 |
Why?
|
| Child | 1 | 2013 | 78492 | 0.000 |
Why?
|
Concepts
(90)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(15)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_